Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Cancer Letters|January 22, 2025
LCAT deficiency promotes hepatocellular carcinoma progression and lenvatinib resistance by promoting triglyceride catabolism and fatty acid oxidationMin Xu, Peiyi Xie, Shaoqing Liu, et al.
Microsystems & Nanoengineering|February 12, 2026
Vertical graphene-coated core-shell microneedle as miniatured sensor for in vivo glucose monitoringJiayi Chen, Shantao Zheng, Yijing Cai, et al.
Journal for Immunotherapy of Cancer|November 5, 2024
WWOX tuning of oleic acid signaling orchestrates immunosuppressive macrophage polarization and sensitizes hepatocellular carcinoma to immunotherapyShaoqing Liu, Shiguang Yang, Min Xu, et al.
Microsystems & Nanoengineering|December 8, 2025
Aptamers-based wearable electrochemical sensors for continuous monitoring of biomarkers in vivoXiaotong Li, Suhang Liu, Xinshuo Huang, et al.
American Journal of Cancer Research|October 12, 2020
High RPS3A expression correlates with low tumor immune cell infiltration and unfavorable prognosis in hepatocellular carcinoma patientsChenhao Zhou, Jialei Weng, Chunxiao Liu, et al.
Clinical & Translational Immunology|December 2, 2024
Squamous cell carcinoma is associated with reduced IL34 expression, alterations in the Langerhans cell antigen-processing-presentation machinery and poor patient survivalThi Viet Trinh Dang, Kevin R Gillinder, Quan Nguyen, et al.
Redox Biology|March 26, 2021
Quiescin sulfhydryl oxidase 1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by driving EGFR endosomal trafficking and inhibiting NRF2 activationJialei Sun, Chenhao Zhou, Yue Zhao, et al.
Nature Communications|January 16, 2026
Robust and interpretable prediction of gene markers and cell types from spatial transcriptomics dataXiao Tan, Onkar Mulay, Jacky Xie, et al.
Stem Cell Research & Therapy|September 24, 2020
Derivation and propagation of spermatogonial stem cells from human pluripotent cellsHuiming Xu, Mengbo Yang, Ruhui Tian, et al.
Nature Communications|February 2, 2024
Targeting ALK averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinomaChunxiao Liu, Chenhao Zhou, Weiya Xia, et al.
Pageof 9